Skip to main content

Table 3 Frequency of use of OAP and/or OAC in association with the cardiovascular risk factors

From: Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland

Risk factor OAP or OAC OAP OAC OAP and OAC
  n (%) n (%) n (%) n (%)
Pharmacologically treated hypertension 1480 1354 151 25
  (50.32%) (46.04%) (5.13%) (0.85%)
Previus myocardial infarct 375 350 35 10
  (67.69%) (63.18%) (6.32%) (1.81%)
Previous stroke 261 237 25 1
  (61.27%) (55.63%) (5.87%) (0.23%)
History of atrial fibrilation 498 396 117 15
  (56.91%) (45.26%) (13.37%) (1.71%)
Coronary heart disease (without myocardial infarct) 426 382 58 14
  (61.21%) (54.89%) (8.33%) (2.01%)
Congestive heart failure 341 290 61 10
  (64.22%) (54.61%) (11.49%) (1.88%)
Pharmacologically treated diabetes 471 432 43 4
  (46.82%) (42.94%) (4.27%) (0.40%)
Pharmacologically treated dyslipidaemia 795 726 86 17
  (63.20%) (57.71%) (6.84%) (1.35%)
Current smoker 132 123 10 1
  (29.40%) (27.39%) (2.23%) (0.22%)
Overweight/obesity 1278 1159 142 23
(BMI ≥ 25 kg/m2) (38.30%) (34.73%) (4.26%) (0.69%)
  1. Data presented as n (%).
  2. OAP - Oral antiplatelet drugs, OAC - Oral anticoagulant drugs.